Callen-Lorde Community Health Center warns of potential public health risk for transgender women and transfeminine people due to a U.S nationwide shortage of some generic and brand name injectable oestrogen. Makers of the drugs have reported manufacturing delays in getting the medications to the market.

Rod of asclepius

“During times like these, we want to stress that suitable alternatives in pill and patch form exist that are safe and effective for people taking oestrogen,” said Callen-Lorde’s Chief Medical Officer Peter Meacher, MD. “Some people perceive that injections are stronger than pills or patches, but physiologically there is little difference between injection, pill or patch.”

“Taking a shot once every two weeks makes it easier for some patients to achieve adherence, rather than taking pills every day or wearing a patch around the clock,” said Anthony Vavasis, MD, Callen-Lorde’s Director of Medicine. “But the safety and effectiveness of taking pills or using a patch while we wait for the injectable medication to be restocked,significantly outweighs the dangers of injecting hormones sold on the street.”

Callen-Lorde understands that some of our patients prefer injectable hormones, and will continue to advocate on behalf of our patients to ensure that the medications they need are available and affordable.

About the Author

Publishes press/media releases and content for LGBT media outlets.